GlassScriptPhysician profile
Molly Shipman
NPI 1518129741
$1,723.17
in general payments reported to CMS, 2019-2025
25 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $120 · 2021: $208 · 2022: $105 · 2023: $551 · 2024: $408 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $236.31 | 2019-2023 | Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $204.99 | 2023-2025 | Myfembree, Gemtesa |
| Cvrx, INC. | $176.46 | 2023 | Barostim Neo System |
| Mayne Pharma Commercial LLC | $163.10 | 2021-2024 | |
| Pfizer INC. | $147.51 | 2021-2024 | |
| Sage Therapeutics, LLC | $111.62 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $85.05 | 2023 | Twirla |
| Avion Pharmaceuticals | $74.36 | 2019-2021 | |
| Astellas Pharma US INC | $71.50 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $58.07 | 2022 | |
| Merck Sharp & Dohme LLC | $54.94 | 2023-2024 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $47.93 | 2019-2024 | Slynd |
| Exact Sciences Corporation | $44.75 | 2023-2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $38.40 | 2019-2021 | |
| Horizon Therapeutics Plc | $34.65 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $23.68 | 2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $22.14 | 2023 | |
| Medicem INC. | $21.28 | 2021 | |
| Amag Pharmaceuticals, INC. | $17.53 | 2019 | |
| Organon LLC | $17.45 | 2021 | |
| Conmed Corporation | $17.31 | 2024 | Airseal |
| Allergan, INC. | $15.76 | 2019 | |
| Kci USA, INC. | $14.35 | 2019 | |
| Millicent US INC | $12.90 | 2019 | |
| Minerva Surgical, INC | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Shipman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.